Efficacy of low-dose rosuvastatin in patients with type 2 diabetes and hypo high-density lipoprotein cholesterolaemia

Objective To analyse the efficacy of low-dose rosuvastatin for treating hypo high-density lipoprotein (HDL) cholesterolaemia in patients with type 2 diabetes and dyslipidaemia. Methods Patients with HDL-cholesterol (C)

Saved in:
Bibliographic Details
Published in:Journal of international medical research 2014-04, Vol.42 (2), p.457-467
Main Authors: Katabami, Takuyuki, Murakami, Mariko, Kobayashi, Suzuko, Matsui, Tomoya, Ujihara, Makoto, Takagi, Sachiko, Higa, Mariko, Ichijo, Takamasa, Ohta, Akio, Tanaka, Yasushi
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Anticholesteremic Agents - therapeutic use
Biological and medical sciences
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Creatine Kinase - blood
Diabetes Mellitus, Type 2 - drug therapy
Diabetes. Impaired glucose tolerance
Dyslipidemias - drug therapy
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Fluorobenzenes - therapeutic use
Glucose - metabolism
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hypolipidemic Agents - therapeutic use
Lipoproteins, HDL - blood
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Prospective Studies
Pyrimidines - therapeutic use
Rosuvastatin Calcium
Sulfonamides - therapeutic use
Triglycerides - blood
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To analyse the efficacy of low-dose rosuvastatin for treating hypo high-density lipoprotein (HDL) cholesterolaemia in patients with type 2 diabetes and dyslipidaemia. Methods Patients with HDL-cholesterol (C)
ISSN:0300-0605
1473-2300
DOI:10.1177/0300060513507648